Targeting Matrix Metalloproteinases in Melanoma Therapy | Promising Role of Selective and Natural Inhibitors

In this episode of SciBud, join Rowan as we uncover groundbreaking research on the potential of matrix metalloproteinases (MMPs) as therapeutic targets in melanoma treatment. With melanoma being one of the most aggressive forms of skin cancer, understanding how MMPs facilitate tumor growth and spread is crucial. We'll delve into the specifics of MMP-2, MMP-9, and MMP-14—enzymes that invade the extracellular matrix and promote angiogenesis—while examining the shift from broad-spectrum inhibitors to more selective, less toxic options. Notably, we'll discuss the promising role of natural MMP inhibitors derived from plants and their potential to enhance treatment effectiveness. Although laboratory results are encouraging, the journey to clinical application is still ongoing. Tune in for an enlightening look at how new discoveries in bioimaging and cancer biology could pave the way for innovative therapies that might one day improve patient outcomes in melanoma! Link to episode page with article citation: www.scibud.media/podcast/season/2026/episode/345